drugset / Trial / NCT02279511
ATP in Alzheimer Disease
RandomizedParallel-groupTriple-blindOther
Summary
To Check whether systemic treatment with ATP alters the profile of cerebral metabolism in patients with Alzheimer's disease using MRS techniques (Magnetic Resonance Spectroscopy) and adjust the infusion (minimum effective dose) that promotes this metabolic change.
Timeline
- Start
- 2014-12
- Primary completion
- 2016-02
- Completion
- 2016-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | adenosine triphosphate | Small molecule | 2.5 g | — |